The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats

Cytokine

Volumn 56, Issue 2, 2011, Pages 343-350

  Zhao, Jinbing ^a   Li, Guangzhao ^b   Zhang, Yang ^a   Su, Xingfen ^a   Hang, Chunhua ^a,b  

^a NANJING UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Anti apoptotic; JAK2; Recombinant human erythropoietin; STAT3; Traumatic brain injury

Indexed keywords

JANUS KINASE 2; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; RECOMBINANT ERYTHROPOIETIN; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CONTUSION; BRAIN CORTEX; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRAUMATIC BRAIN INJURY; UPREGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN INJURIES; DNA PRIMERS; ERYTHROPOIETIN; HUMANS; IN SITU NICK-END LABELING; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; TYRPHOSTINS;

RATTUS;

EID: 80053313829     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.07.018     Document Type: Article

References (43)

1. Langlois J.A., Rutland-Brown W., Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006, 21:375-378.
2. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol 2007, 78:183-205.
3. Xiong Y., Lu D., Qu C., Goussev A., Schallert T., Mahmood A., et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J Neurosurg 2008, 109:510-521.
4. Sola A., Rogido M., Lee B.H., Genetta T., Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 2005, 57:481-487.
5. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76:105-116.
6. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin Sci (Lond) 2002, 103:275-282.
7. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002, 22:393-403.
8. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97:10526-10531.
9. Xiong Y., Mahmood A., Qu C., Kazmi H., Zhang Z.G., Noguchi C.T., et al. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma 2010, 27:205-215.
10. Zhang Y., Xiong Y., Mahmood A., Meng Y., Qu C., Schallert T., et al. Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit. Brain Res 2009, 1294:153-164.
11. Grasso G., Sfacteria A., Meli F., Fodale V., Buemi M., Iacopino D.G. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res 2007, 1182:99-105.
12. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
13. Schindler C. Cytokines and JAK-STAT signaling. Exp Cell Res 1999, 253:7-14.
14. Imada K., Leonard W.J. The Jak-STAT pathway. Mol Immunol 2000, 37:1-11.
15. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74:227-236.
16. Chen G., Zhang S., Shi J., Ai J., Hang C. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 2009, 45:162-168.
17. Feeney D.M., Boyeson M.G., Linn R.T., Murray H.M., Dail W.G. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981, 211:67-77.
18. Yang K., Mu X.S., Xue J.J., Whitson J., Salminen A., dixon C.E., et al. Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res 1994, 664:141-147.
19. Masamune A., Satoh M., Kikuta K., Suzuki N., Shimosegawa T. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. World J Gastroenterol 2005, 11:3385-3391.
20. Tacchini L., Fusar-Poli D., Bernelli-Zazzera A. Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochem Pharmacol 2002, 63:139-148.
21. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
22. Justicia C., Gabriel C., Planas A.M. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 2000, 30:253-270.
23. Osuka K., Watanabe Y., Yamauchi K., Nakazawa A., Usuda N., Tokuda M., et al. Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage. Brain Res 2006, 1072:1-7.
24. Cotena S., Piazza O., Tufano R. The use of erythtropoietin in cerebral diseases. Panminerva Med 2008, 50:185-192.
25. Li Y., Lu Z., Keogh C.L., Yu S.P., Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 2007, 27:1043-1054.
26. Spandou E., Papoutsopoulou S., Soubasi V., Karkavelas G., Simeonidou C., Kremenopoulos G., et al. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res 2004, 1021:167-172.
27. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002, 99:9450-9455.
28. Genc S., Koroglu T.F., Genc K. Erythropoietin and the nervous system. Brain Res 2004, 1000:19-31.
29. Liao Z.B., Zhi X.G., Shi Q.H., He Z.H. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 2008, 15:140-149.
30. Arishima Y., Setoguchi T., Yamaura I., Yone K., Komiya S. Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats. Spine (Phila Pa 1976) 2006, 31:2432-2438.
31. Wen T.C., Sadamoto Y., Tanaka J., Zhu P.X., Nakata K., Ma Y.J., et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res 2002, 67:795-803.
32. Kirito K., Nakajima K., Watanabe T., Uchida M., Tanaka M., Ozawa K., et al. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 2002, 99:102-110.
33. Socolovsky M., Fallon A.E., Wang S., Brugnara C., Lodish H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice. a direct role for Stat5 in Bcl-X(L) induction. Cell 1999, 98:181-191.
34. Cattaneo E., Conti L., De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 1999, 22:365-369.
35. Kretz A., Happold C.J., Marticke J.K., Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 2005, 29:569-579.
36. Lee S.T., Chu K., Sinn D.I., Jung K.H., Kim E.H., Kim S.J., et al. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 2006, 96:1728-1739.
37. Battle T.E., Frank D.A. The role of STATs in apoptosis. Curr Mol Med 2002, 2:381-392.
38. Levy D.E., Lee C.K. What does Stat3 do?. J Clin Invest 2002, 109:1143-1148.
39. Mui A.L. The role of STATs in proliferation, differentiation, and apoptosis. Cell Mol Life Sci 1999, 55:1547-1558.
40. Bolli R., Dawn B., Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 2003, 13:72-79.
41. Seki Y., Kai H., Shibata R., Nagata T., Yasukawa H., Yoshimura A., et al. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000, 87:12-18.
42. Gorina R., Petegnief V., Chamorro A., Planas A.M. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. J Neurochem 2005, 92:505-518.
43. Satriotomo I., Bowen K.K., Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 2006, 98:1353-1368.